NLRP3 and Alzheimer disease: In the study, we injected CY-09, a specific inhibitor of NLRP3, into non-transgenic (NTg) and triple transgenic AD (3×Tg-AD) mice daily, with a dose of 2.5 mg/kg for six weeks, according to the reference [32].